The safety and efficacy of intravenous ketorolac in patients undergoing primary endoscopic sinus surgery: A randomized, double-blinded clinical trial

Nursing and Health Professions

• Patient 100%
• Duragesic 50%
• Pain 33%
• Ketorolac 33%
• Endoscopic Sinus Surgery 33%
• Bleeding 25%
• Analgesic Agent 16%
• Visual Analog Scale 16%
• Postoperative Hemorrhage 16%
• Dose 16%
• Inpatient 16%
• Postoperative Pain 8%
• Tylenol 8%
• Nonsteroid Antiinflammatory Agent 8%
• Hemoglobin 8%
• Hydrocodone 8%
• Intravenous Drug Administration 8%
• Hemoglobin Blood Level 8%
• Anemia 8%
• Nose Septum Reconstruction 8%
• Tonsillectomy 8%
• Time 8%
• Control 8%
• Incidence 8%
• Procedures 8%

INIS

• patients 58%
• pain 41%
• surgery 33%
• sinuses 33%
• doses 25%
• hemorrhage 25%
• risks 16%
• safety 16%
• hemoglobin 16%
• analgesics 16%
• levels 8%
• drugs 8%
• clinical trials 8%
• assessments 8%
• administration 8%
• control 8%
• losses 8%
• inflammation 8%
• anemias 8%
• blood 8%

Medicine and Dentistry

• Fentanyl 50%
• Functional Endoscopic Sinus Surgery 33%
• Pain 33%
• Ketorolac 33%
• Bleeding 25%
• Anodyne 16%
• Visual Analog Scale 16%
• Postoperative Hemorrhage 16%
• Postoperative Pain 8%
• Anemia 8%
• Hemoglobin 8%
• Intravenous Drug Administration 8%
• Paracetamol 8%
• Nonsteroid Antiinflammatory Agent 8%
• Tonsillectomy 8%
• Hydrocodone 8%
• Septoplasty 8%
• Assessment 8%
• Incidence 8%
• Clinical Trial 8%